124results about How to "Improve blood sugar levels" patented technology

This invention comprises a method of treating diabetes. Specifically, the method involves administering one or more anti-fungal agents in amounts, at frequencies, and for durations which are effective in preventing and treating diabetes. The method further comprises the administration of a low carbohydrate diet which may be used either in combination with the aforesaid anti-fungal agent or separately therefrom.

Antibodies that modulate insulin receptor signaling are provided.

The invention provides a diabetes-specific enteral nutrition multi-polymerization agent. The diabetes-specific enteral nutrition multi-polymerization agent comprises the following energy by weight percentage: 50%-60% of carbohydrates, 10%-15% of proteins and 25%-35% of fat, wherein the energy supply ratio of monounsaturated fatty acids is 10-20%. The invention provides the nutrition multi-polymerization agent with balanced nutrients and low GI (glycemic index) value against the metabolic characteristics of diabetic patients, which can effectively correct metabolic disorders, reduce the islet beta-cell load and delay and reduce the occurrence and development of diabetic complications. The diabetes-specific enteral nutrition multi-polymerization agent provided by the invention is particularly suitable for the diabetic patients, patients with severe symptoms, traumas and surgical stress associated with high blood sugar, and people with decreased sugar tolerance.

A method for treating hyperglycemia and/or reducing serum glucose levels in a patient that includes administering to the patient a therapeutically effective amount of an amine polymer is disclosed. In one embodiment, the amine polymer is aliphatic. Examples of polymers useful in an embodiment of the invention include sevelamer hydrogen chloride and colesevelam. The invention includes the use of amine polymers such as a cross-linked polymer characterized by a repeat unit having the formula:

and salts and copolymers thereof, where n is a positive integer and x is zero or an integer between 1 and about 4. Also described is a use, for the manufacture of a medicament, of a polymer that lowers serum glucose.

The invention provides a prophylactic and therapeutic agent of diabetes mellitus, including a combination of an inhibitor of renal glucose reabsorption and a hypoglycemic agent. In accordance with the invention, hyperglycemia after meals, between meals and during fasting can be ameliorated. More specifically, in accordance with the invention, a therapeutic effect of diabetes mellitus as never been obtained by the hypoglycemic agents of the related art can be achieved.

An additive for food and beverage, comprising a compound represented by the general formula (1) or a salt thereof:

• • wherein R¹ to R⁴ are each a glycoside group, a hydroxyl group, or a hydrogen atom, R⁵ is a carboxyl group and R⁶ to R⁸ are each a methyl group or a hydrogen atom.

The invention discloses a weighing analyzing apparatus, comprising a weighing device, a storage device, input/output (I/O) equipment, a component analysis module and a guide module, wherein, the weighing device is used for transmitting a measuring result to the component analysis module; the component analysis module is used for inquiring component information of an object from an object componenttable of the storage device according to an object identification input by the I/O equipment, and calculating the component content of the weighed object according to the measuring weight result; andthe guide module is used for determining a guidance suggestion according to the component content and a preset guide program, and sending the suggestion to the I/O equipment for output. The inventionfurther discloses a weighing analysis method. The invention can realize automatic weighing and calculating, and simply and accurately obtain the guidance suggestion related to object weight.

The invention relates to a self-screened Lactobacillus acidophilus SJLH001 (La SJLH001 for short) with probiotic function of regulating blood sugar and cholesterol level and application thereof in probiotic food. The strain has good tolerance to gastrointestinal environment, and has antioxidant, hydrophobic, ultrasonic resistance, reducing power and other in vitro benefits. In vitro and in vivo functional tests showed that La-SJLH001 has significant amylase inhibitory activity and alpha-Glucose glycerase inhibitory activity, and can significantly reduce fasting blood glucose, postprandial blood glucose level, enhance the tolerance of glucose, alleviate the pancreatic islet enlargement, reduce serum cholesterol level, enhance intestinal mucosal protection and other functions. La- SJLH001 has significant hypoglycemic and cholesterol-lowering activities, which makes it widely used in various forms of probiotic foods (such as probiotic tablet candy, probiotic solid drinks, etc.).

Novel methods for use in identifying or assaying compounds which can simulate the ability of amylin to cause hyperlactemia and hyperglycemia in in vivo biological models, or for use in evaluating the potency of compounds known or suspected to simulate these actions of amylin, which involve introducing test samples into in vivo test systems and determining the presence or amount of a rise in lactate, or determining the presence or amount of a rise in lactate and a rise in glucose, following test sample administration.

The invention relates to a traditional Chinese medicine compound preparation for treating type II diabetes mellitus. The traditional Chinese medicine compound preparation is prepared from the following traditional Chinese medicine raw materials in parts by weight: 5-45 parts of codonopsis pilosula, 5-45 parts of astragalus membranaceus, 5-45 parts of Chinese yam, 5-45 parts of rhizoma polygonati, 1-9 parts of coptis chinensis, 3-27 parts of radix scutellariae, 5-45 parts of radix puerariae and 5-45 parts of ramulus euonymi. The invention also relates to a preparation method of the traditional Chinese medicine compound preparation. The preparation method of the traditional Chinese medicine compound preparation comprises the following steps: weighing traditional Chinese medicine raw materials, adding water for decocting the raw materials, filtering, combining filtrate and concentrating the filtrate; subsequently centrifuging, extracting supernate, concentrating, and adding pharmaceutically acceptable auxiliary materials so as to prepare a conventional preparation form of the traditional Chinese medicine compound preparation with low cost by using a conventional traditional Chinese medicine preparation method. According to the traditional Chinese medicine compound preparation, the therapeutic principle and theory of treatment determination from the spleen are taken as the guidance; the traditional Chinese medicine compound preparation has the functions of reinforcing qi and nourishing yin, strengthening the spleen and clearing heat, activating blood and reducing sugar in the clinical prevention and treatment of the type II diabetes mellitus; meanwhile, the traditional Chinese medicine compound preparation is safe, effective and relatively small in taking amount.

The invention discloses a propolis soft capsule and a preparation method thereof. The propolis soft capsule is prepared by adding an appropriate quantity of auxiliary materials to 100-200 grams of propolis and 300-400 grams of corn oil by weight to prepare 1000 capsule granules. The invention can regulate hyperglycemia, prevent and adjunctively treat diabetes and can also regulate hyperlipemia and reduce worries of obese patients.

A method for the treatment and/or prophylaxis of disorders of the gastrointestinal system, other disorders selected from post exercise recovery, heat stress, vasovagal states, sleep disorders and fluid loss, and for the maintenance of blood sugar level homeostasis, comprising orally administering to said patient an admixture of vitamins and minerals formulated to have a pH greater than or equal to 5.0 in aqueous solution.

The invention relates to a composition with an effect of improving the blood glucose level and a preparation method thereof. The composition is prepared from the following raw materials in parts by weight: 25-40 parts of chestnut shell extract, 10-20 parts of mulberry leaf extract and 3-5 parts of oat beta-glucan, and can be further added with the following components in parts by weight: 5-10 parts of bitter gourd powder, 1-2 parts of chromium containing yeast powder, 5-10 parts of bitter gourd extract, 10-20 parts of barley malt, 5-10 parts of haematococcus pluvialis powder, 3-5 parts of oatfibers, 5-10 parts of Chinese yam meal, 1-2 parts of chrysanthemum powder, 3-5 parts of buckwheat meal, 4-7 parts of polygonatum odoratum powder, 3-5 parts of kudzu vine root powder and 0.1-1 part ofvitamin B2. The composition is rich in nutrition and convenient to eat, can be used for effectively improving the blood glucose level, and has a certain health-protecting effect.

A composition and method of treatment of neuromuscular, neuromuscular degenerative, neurodegenerative, autoimmune, developmental, traumatic, hearing loss related, and/or metabolic diseases, including spinal muscular atrophy (SMA) syndrome (SMA1, SMA2, SMA3, and SMA4, also called Type I, II, III and IV), traumatic brain injury (TBI), concussion, keratoconjunctivitis sicca (Dry Eye Disease), glaucoma, Sjogren's syndrome, rheumatoid arthritis, post-LASIK surgery, anti-depressants use, Wolfram Syndrome, and Wolcott-Rallison syndrome. The composition is selected from the group consisting of 2,3-DNP, 2,4-DNP, 2,5-DNP, 2,6-DNP, 3,4-DNP, or 3,5-DNP, bipartite 2,3-dinitrophenol, 2,4-dinitrophenol, 2,5-dinitrophenol, 2,6-dinitrophenol, 3,4-dinitrophenol, or 3,5-dinitrophenol (2,3-DNP, 2,4-DNP, 2,5-DNP, 2,6-DNP, 3,4-DNP, or 3,5-DNP) prodrugs; Gemini prodrugs, bioprecursor molecules, and combinations thereof. A dose of the composition for treatment of neurodegenerative diseases may be from about 0.01 mg/kg of body weight to about 50 mg/kg of body weight of the patient in need of treatment. A dose of the composition for treatment of metabolic diseases may be from about 1 mg/70 kg of body weight to about 100 mg/70 kg of body weight of the patient in need of treatment, and a maximum dose per day is about 200 mg/70 kg of body weight of the patient in need of treatment.

The invention discloses a composition capable of lowering blood glucose as well as preparation and application of the composition. The composition capable of lowering the blood glucose is prepared from the following components in parts by weight: 50 to 350 parts of folium mori extract, 100 to 500 parts of bitter gourd extract, 75 to 250 parts of American ginseng root extract and 5 to 50 parts of chromium-enriched yeast. The invention further discloses food, medicine or health-care product containing the composition and a related preparation method. According to the composition capable of lowering the blood glucose or tablets capable of lowering the blood glucose, folium mori, bitter gourds, American ginseng root and the chromium-enriched yeast are matched according to a prescription and the use amount of each component is limited; the composition has a remarkable improvement effect on main clinical symptoms of diabetes mellitus.

The invention discloses a citrus bioflavonoid active beverage and a making method thereof. By means of bioflavonoid extracted from biological raw materials through deep processing, the beverage is prepared from, by mass, 80% of water, 8% of fructo-oligose, 7% of polydextrose and 5% of bioflavonoid. The flavonoid functional beverage obtained through the method creates the environment protection benefits, the economic benefits and the social benefits; meanwhile, citrus bioflavonoid has effects of vitamin P samples and can influence the functions of blood vessel wall cells and blood platelets, the functions of white blood cells, the coagulation process, the hemorheology and the formation of thrombus, multi-methoxy compounds such as nobiletin, sinensetin and tangeritin in citrus bioflavonoid have important pharmacological effects, erythrocyte aggregation in human bodies can be reduced, and the blood cell sedimentation rate is decreased.

The invention discloses a neutral vegetable protein drink and a preparation method. The neutral vegetable protein drink comprises, 40-50 parts of walnut protein isolates, 20-30 parts of peanut protein isolates, 6-10 parts of white sugar, 3-6 parts of honey, 1-3 parts of pectase, 1-3 parts of neutral protease, 2-4 parts of fructo-oligosaccharide, 2-4 parts of maltose, 1-3 parts of neutral vegetable protein drink stabilizers and 60-80 parts of purified water. The preparation method of the neutral vegetable protein drink comprises the steps of hydration, preheating, homogenizing, mixing, sterilization and canning and detection and warehousing. The neutral vegetable protein drink is simple in technology, high in producing efficiency and nutrient value, good in taste and worthy of popularization.

The present invention relates to a rice snack which is obtained by using a starting flour which contains a combination of a cereal powder comprising high-amylose rice as the main raw material with a dietary fiber. The present invention also relates to a method for producing a rice snack, which comprises the step of roasting a dough prepared by press-molding a starting flour, which contains a combination of a cereal powder comprising high-amylose rice as the main raw material with a dietary fiber, by the indirect roasting method. According to the invention, there is provided a rice snack by which an increase in the blood sugar level can be effectively regulated and which has an excellent taste.

A measured result reflecting a body condition of a user when measuring a blood sugar level can be displayed, and convenience of management of the blood sugar level of the user is improved. A blood sugar level measuring apparatus includes: a measuring unit to measure a blood sugar level of a user; a recording unit to record measurement data thereof; and a display unit capable of displaying a measured result on a display, wherein the improvement comprises: a condition flag setting unit to record, on the recording unit, a condition flag related to a body condition of the user when measuring the blood sugar level; and a display control unit to display the measured result recorded on the recording unit on the display on the basis of the condition flag set by the condition flag setting unit.

The invention relates to novel nucleic acids encoding a mammalian resistin gene, and proteins encoded thereby, whose expression is suppressed by the antidiabetic compounds thiazolidinediones. The invention further relates to methods of treating and detecting type 2 diabetes and Syndrome X comprising modulating or detecting resistin expression and/or production and activity of resistin polypeptide.

The invention discloses coarse cereal grain bars and a preparation method thereof, and relates to the technical field of process of coarse cereal grain. The coarse cereal grain bars are prepared from, by weight, 70-100 parts of grain, 50-80 parts of auxiliary materials such as nuts and dried fruits and 80-120 parts of a syrup adhesive, and wherein the ratio of the total weight parts of the grain and the auxiliary nut and dried fruit materials to the weight parts of the syrup adhesive is 6:4; the grain raw material involved in a formula of the coarse cereal grain bars has a low glycemic index (GI) value, which is beneficial for improving the blood glucose level of a patient needing blood glucose level reduction through diets, inulin contained in syrup is taken as fructo-oligosaccharide, and the coarse cereal grain bars have advantages of adjusting intestinal flora and the like and are suitable for being eaten by diabetics; the auxiliary materials mainly contain the nuts, the coarse cereal grain bars are crisp in taste, and then through baking, the raw materials present a specific fragrance through the Maillard reaction.